Fibromyalgia Disease

Fibromyalgia disease

     Body aches, fatigue, sleep ... these are some of the atypical symptoms of fibromyalgia disease. It's called fibromyalgia and is known more in the United States and Canada than in Europe. Long ignored in Europe, fibromyalgia disease has attracted the attention of the doctors at specialist conferences.

     But they far from putting on the files of patients the fibromyalgia diagnostic, as do their colleges in America. However, experts of the World Health Organization (WHO) are serious about the fibromyalgia disease. They have developed even an epidemiological data on the disease. According to them, fibromyalgia affects between 2% and 5% of the population, mainly women. Specifically, over 70% of the detected cases of fibromyalgia are in women.

     The pains caused by fibromyalgia are often wrongly diagnosed as being of rheumatic nature, so thus a wrong treatment will be administered with no results.

     We do not know the exact cause of this chronic disease which affects more women than men.

     Often in the medical world fibromyalgia is not considered a disease although the patient is severely debilitated by this affection.

     Fibromyalgia has been studied since the early eighteenth century, under many names, such as muscular rheumatism or fibrosis. Some, considering the fact that this disease affects mostly women, rank it among the group of female hysteria.

     W. Graham made the first modern description of the disease in 1953. In the 1970s and 1980s, it is considered a psychiatric illness with a depressive side. This was inferred from the fact that the pain of the muscle is being resistant to the conventional analgesics at the time.

     Dr. Muhammad B. Yunus published in 1981 the first clinical controlled symptoms of the fibromyalgia disease. The work of Dr. Yunus validates the known symptoms and the tender typical points of this disease. He proposed some diagnostic criteria based on the facts, in the absence of a reliable blood test. In 1984, Yunus suggested a relationship between the fibromyalgia disease and other diseases (such as chronic fatigue syndrome, and in 1986 he demonstrated the effectiveness of drugs based on serotonin and noradrenalin).




     The term "diffuse idiopathic syndrome polyalgique" (DISP) was created by Professor Kahn in the 1980s, but the Anglo-Saxon term fibromyalgia prevailed in medical conferences and has been transformed in the French "fibromyalgie". The fibromyalgia disease has been recognized by the American Medical Association as a debilitating disease in 1987. The American College of Rheumatology committee defines the criteria in 1999. The American College of Rheumatology developed a theory based on a disorder causing neuro hormonal sensitization centrale.

     It was not until 1992 that the World Health Organization has recognized this as a rheumatic disease, whereas it was previously considered a psychiatric illness by physicians, because of its rarity, primarily affecting women, which give some encroachment behavioral and no trace of an organic "syndrome" was wrongly attributed to female hysteria. This alleged cause psychosomatic now being abandoned.

     Indeed, in the 1990s and 2000s, several studies show deficiencies in neurotransmitters in people with fibromyalgia. And in 2006, studies show by functional MRI abnormal activity in the part of the brain that processes pain in fibromyalgia, different activity in people without diabetes. A cause psychiatric and / or psychological abuse is now excluded.

     Fibromyalgia was coded M 70.0 as unspecified rheumatism in the International Classification of Diseases (ICD). Since January 2006, it is now coded in 79.7 under his own name, indicating that the fibromyalgia disease is fully recognized.

     Since 1995, there is a important resurgence (especially since 2000) of this syndrome, more and more young people (under 30) are affected. More and more men are also affected (up to a man for eight women, causing a man for ten women).